# Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial

> **NCT04954625** · NA · ENROLLING_BY_INVITATION · sponsor: **Rush University Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **PROCEDURE:** Autologous Blood Patch
- **PROCEDURE:** Standard of Care (per Physician)

## Key facts

- **NCT ID:** NCT04954625
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-07-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04954625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04954625, "Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04954625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*